Back
Blueprint Medicines Stock Price Chart
Buy
59
BPMC
Blueprint Medicines
Last Price:
104.92
Seasonality Move:
13.7%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and BPMC is experiencing slight selling pressure.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.98 | Sell |
| 20-day SMA: | 101.17 | Buy |
| 50-day SMA: | 94.47 | Buy |
| 200-day SMA: | 73.73 | Buy |
| 8-day EMA: | 105.81 | Sell |
| 20-day EMA: | 102.12 | Buy |
| 50-day EMA: | 96.03 | Buy |
| 200-day EMA: | 79.4 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.16 | Buy |
| Relative Strength Index (14 RSI): | 59.9 | Buy |
| Chaikin Money Flow: | -50627 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.69 - 107.03) | Buy |
| Bollinger Bands (100): | (81.35 - 98.13) | Buy |
Blueprint Medicines Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 104.96 while BPMC 8-day simple moving average is 106.98, which is a Sell signal.
- The stock price of BPMC is 104.96 while Blueprint Medicines 20-day SMA is 101.17, which makes it a Buy.
- Blueprint Medicines 50-day simple moving average is 94.47 while BPMC share price is 104.96, making it a Buy technically.
- BPMC stock price is 104.96 and Blueprint Medicines 200-day simple moving average is 73.73, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
59
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Buy
The current Blueprint Medicines [BPMC] share price is $104.96. The Score for BPMC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
6.57B
Price in USD:
104.96
Share Volume:
415.56K
Blueprint Medicines 52-Week Range
52-Week High:
111.02
52-Week Low:
43.89
Buy
59
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?
The Blueprint Medicines stock price is 104.96 USD today. -
Will BPMC stock go up or go down?
Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators -
Is Blueprint Medicines overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 104.96 while BPMC 8-day exponential moving average is 105.81, which is a Sell signal.
- The stock price of BPMC is 104.96 while Blueprint Medicines 20-day EMA is 102.12, which makes it a Buy.
- Blueprint Medicines 50-day exponential moving average is 96.03 while BPMC share price is 104.96, making it a Buy technically.
- BPMC stock price is 104.96 and Blueprint Medicines 200-day simple moving average is 79.40, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
- Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
- BPMC Moving Average Covergence Divergence (MACD) indicator is 4.16, suggesting Blueprint Medicines is a Buy
- Blueprint Medicines Relative Strength Index (RSI) is 59.9, which suggest Blueprint Medicines is overbought
- The Bollinger Bands (25) for Blueprint Medicines is (89.69 - 107.03), which suggest Blueprint Medicines is a Buy
- The Bollinger Bands (100) for Blueprint Medicines is (81.35 - 98.13), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.